NASDAQ: OLMA - Olema Pharmaceuticals, Inc.

Altı ay boyunca karlılık: +9.15%
Sektör: Healthcare

Promosyon programı Olema Pharmaceuticals, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

Olema Pharmaceuticals, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается открытием, разработкой и коммерциализацией методов лечения рака у женщин. Его ведущей программой является OP-1250, антагонист рецептора эстрогена (ER) и селективный деградиатор ER, который находится в фазе 1/2 клинических испытаний для лечения метастатического или местнораспространенного, ER-положительного и рецептора 2 эпидермального фактора роста человека. -отрицательный рак груди. Компания была ранее известна как CombiThera, Inc. и сменила название на Olema Pharmaceuticals, Inc.

Daha fazla ayrıntı
в марте 2009 года. Olema Pharmaceuticals, Inc. была зарегистрирована в 2006 году, ее штаб-квартира находится в Сан-Франциско, Калифорния.

Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

EV/EBITDA 0.0158
EBITDA -0.0043
Цена ао 11.76
Сайт https://www.olema.com
P/BV 5.59
Число акций ао 0.04525 млрд
Див.доход ао 0
ISIN US68062P1066
Валюта usd
IPO date 2020-11-19
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Günlük fiyat değişimi: +5.82% (11.16)
Haftalık fiyat değişimi: +1.81% (11.6)
Aylık fiyat değişimi: -0.3376% (11.85)
3 ayda fiyat değişimi: -10.12% (13.14)
Altı ayda fiyat değişimi: +9.15% (10.82)
Yıllık fiyat değişimi: +0.5963% (11.74)
3 yılda fiyat değişimi: -55.98% (26.83)
Yılbaşından bu yana fiyat değişimi: -25.63% (15.88)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 2.6 6
P/E 0 0
EV/EBITDA -5.68 0
Toplam: 3.13

Yeterlik

İsim Anlam Seviye
ROA, % -34.9 0
ROE, % -38.07 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0231 10
Toplam: 9.2

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 2332.19 10
karlılık EPS, % 599 10
Toplam: 8
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
BVF Inc. 9135893 16.34
Paradigm Biocapital Advisors LP 7903600 14.14
Logos Global Management LP 4383875 7.84
Blackrock Inc. 3263907 5.84
Vanguard Group Inc 2705895 4.84
Cormorant Asset Management, LP 2456800 4.39
Deep Track Capital, LP 1930894 3.45
Vivo Capital, LLC 1873704 3.35
MPM BioImpact Capital LLC 1857136 3.32
Dimensional Fund Advisors LP 1715420 3.07

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
Avantis U.S Small Cap Equity ETF 0.02117 27.774101036841 1.68271
Avantis U.S. Equity ETF 0.00158 32.224830464267 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.86661 63.040315712071 0.33
ProShares Ultra Nasdaq Biotechnology 0.04759 51.697637072723 0.85651
Dimensional U.S. Core Equity 2 ETF 0.0054 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.00152 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00061 31.530984204131 1.3557
Fidelity MSCI Health Care Index ETF 0.00587 13.390080209527 1.46057
ProShares Hedge Replication ETF 0.00312 5.9237999659878 1.47892
Humankind US Stock ETF 0.00293 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.07319 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.0078 30.095066471445 1.60498
iShares Morningstar Small Cap Value ETF 0.01629 26.701717953559 2.50476
iShares Micro-Cap ETF 0.13817 36.318555985322 1.54048
iShares Russell 2000 Growth ETF 0.01043 38.042556988 0.6026
iShares Russell 3000 ETF 0.00109 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.0078 391.25300933451 1.60498
iShares Morningstar Small-Cap Value ETF 0.01629 227.12514109528 2.50476
Direxion Daily S&P Biotech Bull 3x Shares 0.11012 4067.9190751445 0.25924
SPDR Portfolio MSCI Global Stock Market ETF 0.0013 23.600605143722 2.19607
ProShares UltraPro Russell2000 0.01177 89.821266282945 1.47873
Vanguard U.S. Momentum Factor ETF 0.06 45.845704753962 1.05834
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0.02 35.648084105685 1.48801
Principal Healthcare Innovators ETF 0.07401 618.4964157054 0.8416
Future Tech ETF 0.07401 426.33969118983 0.8416



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Shane William Charles Kovacs M.B.A. Chief Operating & Financial Officer 726.17k 1974 (50 yıllar)
Ms. Julie Dexter Senior VP & Head of People N/A
Dr. Sean P. Bohen M.D., Ph.D. President, CEO & Director 1M 1967 (57 yıllar)
Dr. David C. Myles Ph.D. Chief Discovery & Non-Clinical Development Officer 200k 1963 (61 yıl)
Ms. Demiana Faltaos Ph.D., Pharm.D. VP & Head of Clinical Pharmacology N/A
Dr. Naseem Zojwalla M.D. Chief Medical Officer 775.48k 1973 (51 yıl)
Ms. Sasha Austin CPA VP of Finance & Controller N/A
Mr. John B. Moriarty Jr., ESQ., J.D. Corporate Secretary 1968 (56 yıllar)

Adres: United States, San Francisco, CA , 512 2nd Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.olema.com